Botanical Solution Inc. Secured $7.6 Million in Series A Extension
Botanical Solution Inc. secures $7.6 million to begin in-house production of QS-21, a sustainable vaccine adjuvant derived from plant tissue culture.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.